DIR-Net: Deep Residual Polar Decoding Network Based on Information Refinement

Polar codes are closer to the Shannon limit with lower complexity in coding and decoding. As traditional decoding techniques suffer from high latency and low throughput, with the development of deep learning technology, some deep learning-based decoding methods have been proposed to solve these problems. Usually, the deep neural network is treated as a black box and learns to map the polar codes with noise to the original information code directly. In fact, it is difficult for the network to distinguish between valid and interfering information, which leads to limited BER performance. In this paper, a deep residual network based on information refinement (DIR-NET) is proposed for decoding polar-coded short packets. The proposed method works to fully distinguish the effective and interference information in the codewords, thus obtaining a lower bit error rate. To achieve this goal, we design a two-stage decoding network, including a denoising subnetwork and decoding subnetwork. This structure can further improve the accuracy of the decoding method. Furthermore, we construct the whole network solely on the basis of the attention mechanism. It has a stronger information extraction ability than the traditional neural network structure. Benefiting from cascaded attention modules, information can be filtered and refined step-by-step, thus obtaining a low bit error rate. The simulation results show that DIR-Net outperforms existing decoding methods in terms of BER performance under both AWGN channels and flat fading channels.     

模糊-区间参数连续体结构的拓扑优化设计

研究位移可靠性约束下的模糊-区间参数连续体结构的拓扑优化问题.利用3σ准则和信息熵分别将区间变量和模糊变量近似转换为随机变量,构建了随机参数平面连续体结构的拓扑优化模型,以结构的形状拓扑信息为设计变量,结构总质量均值极小化为目标函数.以满足位移可靠性为约束条件;利用代数综合法导出了位移响应的数字特征的计算表达式;通过单位虚载荷求得位移灵敏度然后采用双方向渐进结构优化方法求解.通过两个算例验证了文中模型的合理性和求解策略的有效性.     

Proteomic Insights into Cardiac Fibrosis: From Pathophysiological Mechanisms to Therapeutic Opportunities

Cardiac fibrosis is a common pathophysiologic process in nearly all forms of heart disease which refers to excessive deposition of extracellular matrix proteins by cardiac fibroblasts. Activated fibroblasts are the central cellular effectors in cardiac fibrosis, and fibrotic remodelling can cause several cardiac dysfunctions either by reducing the ejection fraction due to a stiffened myocardial matrix, or by impairing electric conductance. Recently, there is a rising focus on the proteomic studies of cardiac fibrosis for pathogenesis elucidation and potential biomarker mining. This paper summarizes the current knowledge of molecular mechanisms underlying cardiac fibrosis, discusses the potential of imaging and circulating biomarkers available to recognize different phenotypes of this lesion, reviews the currently available and potential future therapies that allow individualized management in reversing progressive fibrosis, as well as the recent progress on proteomic studies of cardiac fibrosis. Proteomic approaches using clinical specimens and animal models can provide the ability to track pathological changes and new insights into the mechanisms underlining cardiac fibrosis. Furthermore, spatial and cell-type resolved quantitative proteomic analysis may also serve as a minimally invasive method for diagnosing cardiac fibrosis and allowing for the initiation of prophylactic treatment.     

Blue electroluminescent materials based on indeno[1,2-a]arene derivatives for Organic Light-Emitting Diodes

Abstract

In this study, as a continuous effort for searching efficient blue-emitting materials, we designed and synthesized materials based on indeno[1,2-a]arene. OLED devices using these materials were fabricated in the following sequence; ITO (180?nm)/N,N'-diphenyl-N,N'-(2-napthyl)-(1,1'-phenyl)-4,4'-diamine (NPB) (50?nm)/emitting materials (30?nm)/4,7-diphenyl-1,10-phenanthroline (Bphen) (30?nm)/Liq/Al (2/100?nm). Particularly, a device using 7,7-dimethyl-7H-indeno[1,2-a]pyrene as emitter showed maximum values of luminous efficiency, power efficiency, and external quantum efficiency of 1.10?cd/A, 0.49?lm/W, 1.47% at 20?mA/cm², respectively with CIE (x,y) coordinates of (0.15, 0.08) at 6.0V.     

The Biological Fate of Pharmaceutical Excipient β-Cyclodextrin: Pharmacokinetics,Tissue Distribution,Excretion, and Metabolism of β-Cyclodextrin in Rats

β-cyclodextrin has a unique annular hollow ultrastructure that allows encapsulation of various poorly water-soluble drugs in the resulting cavity, thereby increasing drug stability. As a bioactive molecule, the metabolism of β-cyclodextrin is mainly completed by the flora in the colon, which can interact with API. In this study, understanding the in vivo fate of β-cyclodextrin, a LC-MS/MS method was developed to facilitate simultaneous quantitative analysis of pharmaceutical excipient β-cyclodextrin and API dextromethorphan hydrobromide. The established method had been effectively used to study the pharmacokinetics, tissue distribution, excretion, and metabolism of β-cyclodextrin after oral administration in rats. Results showed that β-cyclodextrin was almost wholly removed from rat plasma within 36 h, and high concentrations of β-cyclodextrin distributed hastily to organs with increased blood flow velocities such as the spleen, liver, and kidney after administration. The excretion of intact β-cyclodextrin to urine and feces was lower than the administration dose. It can be speculated that β-cyclodextrin metabolized to maltodextrin, which was further metabolized, absorbed, and eventually discharged in the form of CO₂ and H₂O. Results proved that β-cyclodextrin, with relative low accumulation in the body, had good safety. The results will assist further study of the design and safety evaluation of adjuvant β-cyclodextrin and promote its clinical development.     

Simultaneous Determination of Six Immunosuppressants in Human Whole Blood by HPLC-MS/MS Using a Modified QuEChERS Method

A high-performance liquid chromatography-tandem mass spectrometry method was established for the simultaneous determination of mycophenolic acid, mycophenolate mofetil, tacrolimus, rapamycin, everolimus and pimecrolimus in human whole blood by optimizing the QuEChERS (Quick, Easy, Cheap, Effective, Rugged, and Safe) preparation method. Whole blood was extracted into ethyl acetate, salted out with anhydrous magnesium sulfate, and purified with ethylenediamine-N-propyl silane adsorbent. The supernatant was evaporated under nitrogen until dry and finally reconstituted in methanol. Chromatographic separation was performed on an Agilent Poroshell 120 EC-C18 column in methanol (mobile phase A)-water (optimized for 0.1% acetic acid and 10 mM ammonium acetate, mobile phase B) at a 0.3 mL·min⁻¹ flow rate. Electrospray ionization and positive ion multiple reaction monitoring were used for detection. The time for of analysis was 13 min. The calibration curves range of tacrolimus, rapamycin, everolimus and pimecrolimus were in the range of 1–100 ng·mL⁻¹, mycophenolate mofetil in the range of 0.1–10 ng·mL⁻¹ and mycophenolic acid at 10–1000 ng·mL⁻¹. All correlation coefficients were >0.993. The coefficients of variation (CV, %) for inter-day and intra-day precision were less than 10%, while the spiked recoveries were in the range of 92.1% to 116%. Our method was rapid, sensitive, specific, and reproducible for the simultaneous determination of six immunosuppressants in human whole blood. Importantly, our approach can be used to monitor drug concentrations in the blood to facilitate disease treatment.     

Graphene-encapsulated iron microspheres on the graphene nanosheets

Graphene nanosheets (GNSs) loading graphene-encapsulated iron microspheres (GEIMs) were fabricated by heat treatment of graphene oxide nanosheets (GONs) with ferric trichloride (FeCl(3)). The special pentagon-hexagonal graphene shells have been produced by precipitation of carbon from metal carbide solutions, thanks to the high reactivity of GONs and ferric nanoparticles dispersing homogeneously between graphene layers. The morphology, structure and elemental composition of GEIMs were investigated by scanning electron microscope, X-ray diffraction and electron energy disperse spectroscope, respectively. The formation mechanism of GEIMs was proposed. Hollow graphene microspheres (HGMs) on the GNSs were obtained with the removal of ferric species in GEIMs. When used as the anode materials for lithium-ion batteries, the almost graphitic HGMs exhibit stable voltage platform at ca. 0.2 V, excellent cycle capability and higher reversible capacity of about 440 mAh g(-1) after 50 cycles and possess great potential application in lithium-ion batteries.     

高碘酸氧化法快速测定进口粗甘油中甘油含量

建立了高碘酸氧化法快速测定进口粗甘油中甘油含量的分析方法。对高碘酸钠加入量、溶液pH值和放置时间等主要影响因素进行了考察。经试验确定了最佳实验条件:质量浓度为60 g/L的高碘酸钠溶液加入量35mL,pH值在0.4～1.6之间,放置时间40 min。在选定实验条件下,该方法测定结果的相对标准偏差为1.26%(n=7),加标回收率为97.2%～104.1%。     

3D-structured carbon-coated MnO/graphene nanocomposites with exceptional electrochemical performance for Li-ion battery anodes

MnO has a high theoretical capacity, moderate discharge plateau, and low polarization when it is used as the anode material in lithium battery. However, the issues that limit its application are its poor conductivity and large volume changes, which can easily result in the collapse of electrode structure during long-term cycling. In the present work, a carbon-coated MnO/graphene 3D-network anode material is synthesized by an electrostatic adsorption of dispersed precipitates precipitation method. The MnO nanoparticles coated by carbon are uniformly distributed on the surface of graphene nanosheets and form a 3D sandwich-like nanostructure. A carbon layer is coated on the surface of MnO nanoparticles, which slows down the volume expansion in the process of lithium intercalation. The graphene nanosheets are cross-linked through carbons in this 3D nanostructure, which provides mechanical support and effective electron conduction pathways during the charge-discharge. The electrochemical tests indicate that the prepared 3D carbon-coated MnO/graphene electrode exhibits an excellent rate capacity of 1247.3 and 713.2 mAh g^?1 at 100 and 1000 mA g^?1, respectively. The capacity is 792.2 mAh g^?1 after long cycle at a current density of 1000 mA g^?1. The specific capacity is higher than that of MnO-based composite lithium anode materials currently reported. The superior rate and cycling performances are attributed to the unique 3D-network structure, which provides an effectively conductive network, buffers volume expansion, and prevents falling and aggregation of MnO in the charge and discharge process of the electrode materials. The 3D-structured carbon-coated MnO/graphene anode material will have an excellent application prospect.

Open image in new window

Graphical abstract Cyclic performance at 1 A g^?1 and SEM images (inset) of the 3D-structured carbon-coated MnO/graphene nanocomposite.